“Last week we provided an important update detailing the launch of AL-LAD, you can read it here. We chose not to clutter that email with further details and updates, so this email will serve as our official October newsletter.
In our quest for the perfect MXE analogue, we are pleased to announce the release of another dissociative product, DMXE (deoxymethoxetamine, 3-Me-2’-oxo-PCE hydrochloride). This molecule is structurally very similar to MXE, with only the methoxy replaced with methyl (oxygen removed and hence the ‘deoxy’).
As with each iteration of our MXE analogues, we get closer and closer to the original. And whilst DMXE has it’s own unique and special flavour, it is extremely similar to MXE. As we demonstrated with 3-Me-PCP, the 3-MeO group can be substituted with methyl without loss of potency or significant alteration of pharmacological profile. We are pleased to see that the 2’-oxo compounds follow the same SAR, from the several we have synthesised, including DMXE.”